| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider activity in ARWR over the last quarter tilts toward selling: insiders offloaded a net 13,600 shares worth roughly $1.2M.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 3.79M | $225.78M | - | |
| COO | 547.4K | $32.59M | - | |
| Other | 227.0K | $13.51M | - | |
| CFO | 162.9K | $9.70M | - | |
| Dir | 111.5K | $6.64M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 20, 2024 | Hongbo Lu61 | Director | Buy | 3,000 | $27.66 | $82,990.00 | +9.8% | -16.3% | -46.3% | |
| Mar 6, 2024 | Kenneth Allen Myszkowski68 | Chief Financial Officer | Sell | 40,000 | $35.19 | $1,407,600.00 | -9.1% | -28.6% | -50.1% | |
| Jan 31, 2024 | Christopher Richard Anzalone60 | Chief Executive Officer | Sale+OE10b5-1 | 57,499 | $32.35 | $1,860,019.34 | -1.5% | -29.5% | -37.0% | |
| Jan 12, 2024 | James C Hamilton58 | Chief Discovery/ Trans Medicine | Sell10b5-1 | 7,940 | $36.89 | $292,903.60 | -3.6% | -29.5% | -49.2% | |
| Jan 11, 2024 | Douglas B Given66 | Director | Sell10b5-1 | 2,911 | $38.06 | $110,788.36 | -2.2% | -32.3% | -50.7% | |
| Jan 11, 2024 | William D. Waddill | Director | Sell10b5-1 | 3,934 | $38.07 | $149,758.54 | -7.6% | -32.3% | -50.7% | |
| Jan 11, 2024 | Mauro Ferrari71 | Director | Sell10b5-1 | 3,147 | $38.06 | $119,786.60 | -4.9% | -32.3% | -50.7% | |
| Jan 11, 2024 | Victoria Vakiener53 | Director | Sell10b5-1 | 4,720 | $38.10 | $179,813.40 | -12.9% | -32.3% | -50.7% | |
| Jan 5, 2024 | Tracie Oliver70 | Chief Commercial Officer | Sell10b5-1 | 74 | $33.89 | $2,507.86 | - | -26.7% | -44.4% | |
| Jan 5, 2024 | Kenneth Allen Myszkowski68 | Chief Financial Officer | Sell10b5-1 | 16,104 | $35.27 | $567,909.60 | -3.5% | -26.7% | -44.4% |